Fer kinase regulates cell migration through α-dystroglycan glycosylation

Molecular Biology of the Cell

Volumn 23, Issue 5, 2012, Pages 771-780

  Yoneyama, Tohru ^a,c   Angata, Kiyohiko ^a,d   Bao, Xingfeng ^a,e   Courtneidge, Sara ^a   Chanda, Sumit K ^b   Fukuda, Minoru ^a  

^a Cancer Center   (United States)

^b BURNHAM INSTITUTE   (United States)

^c HIROSAKI UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e EISAI RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BETA3 N ACETYLGLUCOSAMINYLTRANSFERASE 1; GLYCOSYLTRANSFERASE; LAMININ BINDING PROTEIN; LIKE ACETYLGLUCOSAMINYLTRANSFERASE; MANNOSYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN KINASE FER; PROTEIN O MANNOSYLTRANSFERASE 1; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MEMBRANE BINDING; MOLECULAR LIBRARY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SCREENING;

BASEMENT MEMBRANE; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; DYSTROGLYCANS; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; HUMANS; LAMINS; MANNOSYLTRANSFERASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 84857873822     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-06-0517     Document Type: Article

References (49)

1. Angata K, Huckaby V, Ranscht B, Terskikh A, Marth JD, Fukuda M (2007). Polysialic acid-directed migration and differentiation of neural precursors are essential for mouse brain development. Mol Cell Biol 27, 6659-6668. (Pubitemid 47483620)
2. Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, Fukuda MN, Fukuda M (2009). Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci USA 106, 12109-12114.
3. Barresi R, Campbell KP (2006). Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119, 199-207.
4. Barresi R et al. (2004). LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 10, 696-703. (Pubitemid 38937634)
5. Brockington M et al. (2001). Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69, 1198-1209. (Pubitemid 33124201)
6. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr (1999). Stat3 as an oncogene. Cell 98, 295-303. (Pubitemid 29380565)
7. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T (1997). Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 272, 2156-2162. (Pubitemid 27058494)
8. Cole LA, Zirngibl R, Craig AW, Jia Z, Greer P (1999). Mutation of a highly conserved aspartate residue in subdomain IX abolishes Fer protein-tyrosine kinase activity. Protein Eng 12, 155-162. (Pubitemid 29103694)
9. Craig AW, Zirngibl R, Williams K, Cole LA, Greer PA (2001). Mice devoid of Fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol 21, 603-613. (Pubitemid 32037378)
10. de Bernabe DB, Inamori K, Yoshida-Moriguchi T, Weydert CJ, Harper HA, Willer T, Henry MD, Campbell KP (2009). Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J Biol Chem 284, 11279-11284.
11. Ding L et al. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075.
12. El Sayegh TY, Arora PD, Fan L, Laschinger CA, Greer PA, McCulloch CA, Kapus A (2005). Phosphorylation of N-cadherin-associated cortactin by Fer kinase regulates N-cadherin mobility and intercellular adhesion strength. Mol Biol Cell 16, 5514-5527. (Pubitemid 41752203)
13. Ferletta M, Kikkawa Y, Yu H, Talts JF, Durbeej M, Sonnenberg A, Timpl R, Campbell KP, Ekblom P, Genersch E (2003). Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol Biol Cell 14, 2088-2103. (Pubitemid 36583555)
14. Fukuda A et al. (2011). Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441-455.
15. Godfrey C et al. (2007). Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130, 2725-2735. (Pubitemid 47511718)
16. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, Sanes JR (1999). Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1, 215-220. (Pubitemid 129500940)
17. Greer P (2002). Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 3, 278-289.
18. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE (2001). Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet 28, 151-154. (Pubitemid 32538060)
19. Hayun R, Shpungin S, Malovani H, Albeck M, Okun E, Nir U, Sredni B (2007). Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer. Ann NY Acad Sci 1095, 240-250. (Pubitemid 47092456)
20. Jing J, Lien CF, Sharma S, Rice J, Brennan PA, Gorecki DC (2004). Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer 40, 2143-2151. (Pubitemid 39165549)
21. Kanagawa M et al. (2004). Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117, 953-964. (Pubitemid 38798860)
22. Kobayashi K et al. (1998). An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392. (Pubitemid 28373837)
23. Konig R et al. (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60.
24. Konig R et al. (2010). Human host factors required for influenza virus replication. Nature 463, 813-817.
25. Kwabi-Addo B, Ozen M, Ittmann M (2004). The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11, 709-724. (Pubitemid 40065546)
26. Larsen M, Artym VV, Green JA, Yamada KM (2006). The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18, 463-471. (Pubitemid 44332914)
27. Lee SH et al. (2008). Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway mediated by p120catenin, Fer, SHP-2, and beta-catenin. J Cell Biol 183, 893-908.
28. Lesina M et al. (2011). Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456-469.
29. Levayer R, Lecuit T (2008). Breaking down EMT. Nat Cell Biol 10, 757-759. (Pubitemid 351927703)
30. Li N, Grivennikov SI, Karin M (2011). The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19, 429-431.
31. Longman C et al. (2003). Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12, 2853-2861. (Pubitemid 37407122)
32. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T (2004). Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA 101, 500-505. (Pubitemid 38084665)
33. Muntoni F et al. (2007). Muscular dystrophies due to defective glycosylation of dystroglycan. Acta Myol 26, 129-135. (Pubitemid 351668920)
34. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ (2002). A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 62, 7102-7109. (Pubitemid 35424106)
35. Pasder O, Shpungin S, Salem Y, Makovsky A, Vilchick S, Michaeli S, Malovani H, Nir U (2006). Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 25, 4194-4206. (Pubitemid 44079453)
36. Patnaik SK, Stanley P (2005). Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. J Biol Chem 280, 20851-20859. (Pubitemid 40776790)
37. Peyrard M et al. (1999). The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci USA 96, 598-603. (Pubitemid 29061254)
38. Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M (2003). p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha- catenin Interaction. Mol Cell Biol 23, 2287-2297. (Pubitemid 36351012)
39. Polyak K, Weinberg RA (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265-273.
40. Priel-Halachmi S, Ben-Dor I, Shpungin S, Tennenbaum T, Molavani H, Bachrach M, Salzberg S, Nir U (2000). FER kinase activation of Stat3 is determined by the N-terminal sequence. J Biol Chem 275, 28902-28910.
41. Sasaki K, Kurata-Miura K, Ujita M, Angata K, Nakagawa S, Sekine S, Nishi T, Fukuda M (1997). Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc Natl Acad Sci USA 94, 14294-14299.
42. Sgambato A, De Paola B, Migaldi M, Di Salvatore M, Rettino A, Rossi G, Faraglia B, Boninsegna A, Maiorana A, Cittadini A (2007). Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J Cell Physiol 213, 528-539. (Pubitemid 47509736)
43. Shimojo H, Kobayashi M, Kamigaito T, Shimojo Y, Fukuda M, Nakayama J (2011). Reduced glycosylation of &αλπηα;- dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer. Prostate 71, 1151-1157.
44. Spence HJ, Dhillon AS, James M, Winder SJ (2004). Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 5, 484-489. (Pubitemid 38745039)
45. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ (2004). Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6, 159-170. (Pubitemid 39485688)
46. Xu G, Craig AW, Greer P, Miller M, Anastasiadis PZ, Lilien J, Balsamo J (2004). Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer. J Cell Sci 117, 3207-3219. (Pubitemid 39139907)
47. Yoshida A et al. (2001). Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 1, 717-724. (Pubitemid 33586123)
48. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP (2010). O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327, 88-92.
49. Zoubeidi A, Rocha J, Zouanat FZ, Hamel L, Scarlata E, Aprikian AG, Chevalier S (2009). The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth. Mol Cancer Res 7, 142-155.